Spots Global Cancer Trial Database for IDEntification of New Predisposition Genes in Differentiated THYroid Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: IDEntification of New Predisposition Genes in Differentiated THYroid Cancer
Official Title: IDEntification of New Predisposition Genes in Differentiated THYroid Cancer
Study ID: NCT05014698
Interventions
Study Description
Brief Summary: The purpose of this research is to find new predisposition genes for differentiated thyroid cancer (DTC).
Detailed Description: The purpose of this research is to find new predisposition genes for differentiated thyroid cancer (DTC). Therefore, in the absence of a BAP1 and DICER1 abnormality, we offer to sequence your whole genome (WGS) or partial genome (genotyping) for a previously unknown genetic abnormality. Furthermore, the discovery of new genes would be a major medical advance that could contribute to the identification of new therapeutic targets. This research will be conducted at the University Hospital of Nantes and the Hospital of Vendée and 95 people should participate.
Keywords
Eligibility
Minimum Age: 8 Years
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
Locations
Vendée Hospital, La Roche-sur-Yon, , France
Nantes University Hospital, Nantes, , France
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
